The efficacy of pulmonary thromboendarterectomy on long-term gas exchange

It has not been delineated in detail how pulmonary thromboendarterectomy (PTE) affects gas exchange through long-term follow-up. In Japan, this surgery has been undertaken in a limited number of institutions, and the results of PTE have not been well publicized. A total of 25 patients were operated on during the period from 1985 to 1996 at our institution, and the overall mortality rate was 16%. Our criteria for PTE were based on the following: 1) thrombi surgically accessible as judged by angiographic study; 2) mean pulmonary arterial pressure > or = 30 mmHg. The efficacies of PTE were analysed on haemodynamics as well as gas exchange at one month postsurgery and during follow-up (6-24 months). Significant haemodynamic improvement was obtained as early as 1 month after surgery. Improvement of gas exchange lagged, but was then observed during follow-up, and the improvement level of pulmonary haemodynamics was sustained. The early postoperative restrictive impairment and ventilation-perfusion abnormality on lung perfusion scan resolved during the follow-up period. It was concluded that the early postoperative efficacy of pulmonary throm-boendarterectomy was mainly achieved due to the reduction of pulmonary hypertension, whereas improvement in gas exchange was obtained over the longer term.

This article has been cited by other articles:

				A. G. Corsico, A. M. D'Armini, I. Cerveri, C. Klersy, E. Ansaldo, R. Niniano, E. Gatto, C. Monterosso, M. Morsolini, S. Nicolardi, et al. Long-term Outcome after Pulmonary Endarterectomy Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 419 - 424. [Abstract] [Full Text] [PDF]

				H. Matsuda, H. Ogino, K. Minatoya, H. Sasaki, N. Nakanishi, S. Kyotani, J. Kobayashi, T. Yagihara, and S. Kitamura Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann. Thorac. Surg., October 1, 2006; 82(4): 1338 - 1343. [Abstract] [Full Text] [PDF]

				N. Tanabe, A. Kimura, S. Amano, O. Okada, Y. Kasahara, K. Tatsumi, M. Takahashi, H. Shibata, M. Yasunami, and T. Kuriyama Association of clinical features with HLA in chronic pulmonary thromboembolism Eur. Respir. J., January 1, 2005; 25(1): 131 - 138. [Abstract] [Full Text] [PDF]

				R. L. Doyle, D. McCrory, R. N. Channick, G. Simonneau, and J. Conte Surgical Treatments/Interventions for Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 63S - 71S. [Abstract] [Full Text] [PDF]

				M C Zoia, A M D'Armini, M Beccaria, A Corsico, P Fulgoni, C Klersy, F Piovella, M Vigano, and I Cerveri Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status Thorax, July 1, 2002; 57(7): 608 - 612. [Abstract] [Full Text] [PDF]

				H. KIMURA, O. OKADA, N. TANABE, Y. TANAKA, M. TERAI, Y. TAKIGUCHI, M. MASUDA, N. NAKAJIMA, K. HIROSHIMA, H. INADERA, et al. Plasma Monocyte Chemoattractant Protein-1 and Pulmonary Vascular Resistance in Chronic Thromboembolic Pulmonary Hypertension Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 319 - 324. [Abstract] [Full Text] [PDF]

				P. A. Thistlethwaite, S. H. Lee, L.-L. Du, P. L. Wolf, C. Sullivan, S. Pradhan, R. Deutsch, and S. W. Jamieson Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 65 - 73. [Abstract] [Full Text] [PDF]

				N. Tanabe, O. Okada, Y. Abe, M. Masuda, N. Nakajima, and T. Kuriyama The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy Eur. Respir. J., April 1, 2001; 17(4): 653 - 659. [Abstract] [Full Text] [PDF]